mRNA-1018-H5 Pandemic Influenza Vaccine

mRNA-1018-H5 influenza vaccine · ModernaTX, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mRNA-1018-H5 Pandemic Influenza Vaccine, covering 2026-04-03 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults [Phase 3]